HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The goals of this Funding Opportunity Announcement (FOA) are to stimulate further research on delineating the pathophysiology of HIV-1 associated CNS disease in the setting of chronic viral suppression and ART. In addition, FOA also encourages research studies to aid in the identification/ validation of biomarkers and pre-clinical targets with quantifiable readouts in domestic and international settings. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Companion FOA: PA-20-151  Eradication of HIV-1 from Central Nervous system Reservoirs

Deadlines: Jan. 7, May 7, Sep. 7

PA-20-149 Expiration Date May 08, 2023




Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

May 7, 2023